Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Zero based budgeting explains how every dollar gets a purpose, driving intentional spending and improved financial outcomes.
18,378 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Mastercard plans to buy London-based BVNK for up to $1.8 billion, creating the largest stablecoin deal to date and ac...
A no-action relief granted to Phantom allows crypto wallets to function as consumer interfaces for regulated derivati...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
Rocket Lab is expanding by purchasing a competing space systems group for up to $60 million. This article breaks down...
Brookfield plans value per share offers a long‑term lens on value. This guide explains the metric, how it links to th...
Auna's Q1 2026 earnings signal a mixed yet resilient growth path. This analysis breaks down revenue, margins, and gui...
Micron stock has surged as AI memory demand grows. With a gain of 214% this year, late investors wonder if now is the...
A high-stakes order from China could reshape Boeing’s revenue trajectory. Here’s how to think about the stock in 2026...
Federal regulators are probing George Santos over Kalshi trades linked to his State of the Union attendance, a high p...